type here...

News

What we are reading

Gilead’s Coronavirus Treatment Remdesivir to Cost $3,120 per U.S. Patient With Private Insurance

ProMarket writers
What we are reading

11 Top Antitrust Experts Alarmed by Whistleblower Complaint Against A.G. Barr—and Office of Professional Responsibility’s Opinion

ProMarket writers
Media

Bethany McLean’s Weekend Reading List: Wirecard, Shale Oil, and the Fall of Chuck E. Cheese

Bethany McLean
Corruption, lobbying, corporate malfeasance, and frauds: a weekly unconventional selection of must-read articles by investigative journalist Bethany McLean.  OMG, we're missing $2 billion! That, in a...
What we are reading

How Amazon Used the Pandemic to Amass More Monopoly Power

ProMarket writers
Commentary

Should Small Businesses Consider Bankruptcy? A New Capitalisn’t Reading List

ProMarket writers
The coronavirus has taken a heavy toll on most businesses, but it has been especially hard on small businesses. Should those businesses file for...
What we are reading

Facebook Announces New Hate Speech and Misinformation Policies Amid Advertiser Revolt

ProMarket writers
What we are reading

The House Just Passed a Sweeping Police Reform Bill

ProMarket writers
What we are reading

Verizon Joins Facebook Advertising Boycott

ProMarket writers
What we are reading

EY Failed to Ask for Wirecard Bank Statements for 3 Years

ProMarket writers
What we are reading

Fed Limits Bank Payouts and Suspends Share Buybacks as Pandemic Grinds On

ProMarket writers
1...370371372...400Page 371 of 400

Latest news

View All

The publication of the Stigler Center at The University of Chicago Booth School of Business

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.